Seminars in Hematology
Volume 44, Supplement 1 , Pages 15-24, January 2007

Resistance to Targeted Therapy in Chronic Myelogenous Leukemia

III. Medizinische Klinik, Medizinische Fakultät Mannheim, University of Heidelberg, Mannheim, Germany.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the Competence Network “Acute and Chronic Leukemias,” sponsored by the German Bundesministerium für Bildung und Forschung (Projektträger Gesundheitsforschung; DLR e.V.- 01 GI9980/6), and the European LeukemiaNet within the 6th European Community Framework Program for Research and Technological Development.

PII: S0037-1963(06)00255-1

doi:10.1053/j.seminhematol.2006.12.002

Seminars in Hematology
Volume 44, Supplement 1 , Pages 15-24, January 2007

Article Tools